DrugPatentWatch Database Preview

Betrixaban - Generic Drug Details

What are the generic sources for betrixaban and what is the scope of betrixaban freedom to operate?

Betrixaban is the generic ingredient in one branded drug marketed by Portola Pharms Inc and is included in one NDA. There are ten patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Betrixaban has one hundred and twenty-six patent family members in thirty-one countries.

One supplier is listed for this compound.

Summary for betrixaban

International Patents:	126
US Patents:	10
Tradenames:	1
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	52
Clinical Trials:	9
Patent Applications:	117
Formulation / Manufacturing:	see details
DailyMed Link:	betrixaban at DailyMed

Pharmacology for betrixaban

Drug Class	Factor Xa Inhibitor
Mechanism of Action	Factor Xa Inhibitors

Synonyms for betrixaban

330942-05-7
4CA-0269
74RWP7W0J9
942B057
AB0027977
AB1008465
ABP000384
AC-30214
AKOS005146070
AN-3565
API0007103
BC638590
BCP01903
BCP9000395
BDBM50249298
Benzamide, N-(5-chloro-2-pyridinyl)-2-((4-((dimethylamino)iminomethyl)benzoyl)amino)-5-methoxy-
Betrixaban (USAN)
Betrixaban [USAN:INN]
betrixaban/
Bevyxxa
CHEBI:140421
CHEMBL512351
compound 11 [PMID: 19297154]
CS-2481
D08873
DB12364
EX-A358
FT-0663094
GTPL9602
HY-10268
KB-75507
KS-00000645
MolPort-009-682-948
N-(5-Chloro-2-pyridinyl)-2-[[4-[(dimethylamino)iminomethyl]benzoyl]amino]-5-methoxybenzamide
N-(5-chloro-2-pyridyl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-5-methoxy-benzamide
N-(5-Chloropyridin-2-yl)-2-((4-(N,N-dimethylcarbamimidoyl)benzoyl)amino)-5- methoxybenzamide
N-(5-chloropyridin-2-yl)-2-({[4-(N,N-dimethylcarbamimidoyl)phenyl]carbonyl}amino)-5-methoxybenzamide
N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide
N-(5-Chloropyridin-2-yl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-5-methoxybenzamide
N-(5-chloropyridin-2-yl)-2-[4-(N,N-dimethylcarbamimidoyl)benzamido]-5-methoxybenzamide
NCGC00371122-02
PRT 054021
PRT-054021
PRT054021
QCR-99
SB16951
SCHEMBL158591
UNII-74RWP7W0J9
VA11998
W9900
ZINC30691754

US Patents and Regulatory Information for betrixaban

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Portola Pharms Inc	BEVYXXA	betrixaban	CAPSULE;ORAL	208383-002	Jun 23, 2017		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Portola Pharms Inc	BEVYXXA	betrixaban	CAPSULE;ORAL	208383-002	Jun 23, 2017		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Portola Pharms Inc	BEVYXXA	betrixaban	CAPSULE;ORAL	208383-002	Jun 23, 2017		RX	Yes	Yes	➤ Sign Up	➤ Sign Up		Y		➤ Sign Up
Portola Pharms Inc	BEVYXXA	betrixaban	CAPSULE;ORAL	208383-001	Jun 23, 2017		RX	Yes	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Portola Pharms Inc	BEVYXXA	betrixaban	CAPSULE;ORAL	208383-001	Jun 23, 2017		RX	Yes	No	➤ Sign Up	➤ Sign Up		Y		➤ Sign Up
Portola Pharms Inc	BEVYXXA	betrixaban	CAPSULE;ORAL	208383-001	Jun 23, 2017		RX	Yes	No	➤ Sign Up	➤ Sign Up	Y	Y		➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

International Patents for betrixaban

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration
Portugal	1948608	➤ Sign Up
Brazil	PI0014076	➤ Sign Up
Portugal	2513058	➤ Sign Up
Russian Federation	2002110295	➤ Sign Up
Ecuador	SP099501	➤ Sign Up
China	101304971	➤ Sign Up
Country	Patent Number	Estimated Expiration